Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress in targeting HIV-1 entry.

Hugues J-P Ryser1, Rudolf Flückiger

  • 1Departments of Pathology and Pharmacology, Boston University School of Medicine, Boston, MA 02118, USA. hryser@bu.edu

Drug Discovery Today
|September 27, 2005
PubMed
Summary

New research identifies cell surface protein disulfide isomerase (PDI) as a potential target for inhibiting HIV-1 entry. Inhibiting PDI activity or its interactions with viral proteins prevents HIV-1 from entering cells.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DAF in diabetic patients is subject to glycation/inactivation at its active site residues.

Molecular immunology·2017
Same author

The Co-Metabolism within the Gut-Brain Metabolic Interaction: Potential Targets for Drug Treatment and Design.

CNS & neurological disorders drug targets·2016
Same author

Improvement of tendon repair using muscle grafts transduced with TGF-β1 cDNA.

European cells & materials·2012
Same author

Effect of BMP-12, TGF-β1 and autologous conditioned serum on growth factor expression in Achilles tendon healing.

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA·2011
Same author

Accelerated healing of the rat Achilles tendon in response to autologous conditioned serum.

The American journal of sports medicine·2009
Same author

Modulation of bone resorption by phosphorylation state of bone sialoprotein.

Biochemistry·2009

Area of Science:

  • Virology
  • Molecular Biology
  • Biochemistry

Background:

  • Current HIV entry inhibitors target viral glycoproteins gp120 and gp41 interactions with cellular receptors.
  • The precise mechanisms governing HIV-1 entry and the role of cellular factors are still under investigation.

Purpose of the Study:

  • To explore novel therapeutic targets for HIV-1 entry inhibition.
  • To investigate the role of cell surface protein disulfide isomerase (PDI) in HIV-1 entry.

Main Methods:

  • Investigated the interaction between cell surface PDI, the cellular receptor CD4, and the HIV-1 envelope glycoproteins gp120 and gp41.
  • Assessed the effect of inhibiting PDI activity and its interaction sites on HIV-1 entry into host cells.

Main Results:

  • Cell surface PDI binds to the cellular CD4 receptor near the gp120 binding site.
  • PDI may facilitate HIV-1 entry by reducing disulfide bonds in gp120, triggering conformational changes necessary for fusion.
  • Inhibition of cell surface PDI effectively blocks HIV-1 entry.

Conclusions:

  • Cell surface PDI represents a novel and promising target for developing new anti-HIV-1 entry inhibitors.
  • Targeting PDI activity or its interaction sites (PDI-CD4, PDI-gp120) offers a new strategy to combat HIV-1 infection.

Related Experiment Videos